J&J spends $16.6 billion to acquire Abiomed, a manufacturer of miniature heart pumps
Michael Minogue, who is now Abiomed’s chairman, president, and CEO, will retire after the purchase closes. After helping with the transfer, he will hand over leadership of the independent business to Chief Commercial Officer Andrew Greenfield, who will manage J&J’s medtech division. Johnson & Johnson intends to include Abiomed into its pantheon of medical technology … Continue reading J&J spends $16.6 billion to acquire Abiomed, a manufacturer of miniature heart pumps